John G. Saia - 01 Sep 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Senior Vice President, General Counsel and Corporate Secretary.
Signature
/s/ John G. Saia
Issuer symbol
GH
Transactions as of
01 Sep 2022
Net transactions value
-$35,764
Form type
4
Filing time
13 Sep 2022, 16:17:23 UTC
Previous filing
10 Aug 2022
Next filing
09 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +1,052 +7.9% $0.000000 14,343 01 Sep 2022 Direct
transaction GH COMMON STOCK Tax liability $17,861 -364 -2.5% $49.07 13,979 01 Sep 2022 Direct F1
transaction GH COMMON STOCK Tax liability $17,903 -302 -2.2% $59.28 13,677 09 Sep 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -1,052 -25% $0.000000 3,157 01 Sep 2022 COMMON STOCK 1,052 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each quarterly anniversary of September 1, 2022, during the three-year period thereafter.
F3 Not applicable to Restricted Stock Units.

Remarks:

Senior Vice President, General Counsel and Corporate Secretary.